508
Participants
Start Date
March 12, 2013
Primary Completion Date
May 22, 2014
Study Completion Date
June 12, 2014
Etelcalcetide
Administered intravenously three times per week. The starting dose was 5 mg. The dose may have been increased at 4-week intervals by 2.5 mg or 5 mg on the basis of the predialysis parathyroid hormone and corrected calcium concentrations obtained in the prior week. The minimum dose was 2.5 mg and the maximum dose was 15 mg.
Placebo
Administered intravenously (IV) three times per week.
Research Site, Brussels
Research Site, Budapest
Research Site, Vienna
Research Site, Budapest
Research Site, St Leonards
Research Site, Liverpool
Research Site, Leuven
Research Site, Prahan
Research Site, Parkville
Research Site, Liège
Research Site, Linz
Research Site, Baja
Research Site, Baudour
Research Site, Kaposvár
Research Site, Pécs
Research Site, Graz
Research Site, Győr
Research Site, Aalst
Research Site, The Bronx
Research Site, Yonkers
Research Site, Brooklyn
Research Site, Rosedale
Research Site, Berlin
Research Site, Amherst
Research Site, Allentown
Research Site, Philadelphia
Research Site, Philadelphia
Research Site, Milan
Research Site, San Fermo Della Battaglia (CO)
Research Site, Fairfax
Research Site, Nahariya
Research Site, Mechanicsville
Research Site, Norfolk
Research Site, Kiel
Research Site, Bluefield
Research Site, Pavia
Research Site, Chapel Hill
Research Site, Durham
Research Site, Madrid
Research Site, Madrid
Research Site, Orangeburg
Research Site, Sumter
Research Site, Pembroke Pines
Research Site, Birmingham
Research Site, Verona
Research Site, Nashville
Research Site, Columbia
Research Site, Tupelo
Research Site, Santander
Research Site, Nantes
Research Site, Southgate
Research Site, Detroit
Research Site, Pontiac
Research Site, Kalamazoo
Research Site, Reims
Research Site, Evanston
Research Site, Kansas City
Research Site, Tel Aviv
Research Site, Pine Bluff
Research Site, Grand Prairie
Research Site, Tyler
Research Site, Mansfield
Research Site, Fort Worth
Research Site, Fort Worth
Research Site, Houston
Research Site, Villingen-Schwenningen
Research Site, San Antonio
Research Site, San Antonio
Research Site, San Antonio
Research Site, Ashkelon
Research Site, Austin
Research Site, Salouël
Research Site, Napoli
Research Site, Meridian
Research Site, Poitiers
Research Site, Reno
Research Site, Los Angeles
Research Site, Lynwood
Research Site, Whittier
Research Site, Lakewood
Research Site, Northridge
Research Site, Panorama City
Research Site, Azusa
Research Site, Covina
Research Site, Ontario
Research Site, Saint-Ouen
Research Site, Sacramento
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Springfield
Research Site, Brampton
Research Site, Greenfield Park
Research Site, Montreal
Research Site, Québec
Research Site, Hradec Králové
Research Site, Prague
Research Site, Praha 4 - Nusle
Research Site, Slavkov u Brna
Research Site, Třinec
Research Site, Dresden
Research Site, Bialystok
Research Site, Warsaw
Research Site, Warsaw
Research Site, Warsaw
Research Site, Wroclaw
Research Site, Zamość
Research Site, Barcelona
Research Site, Barcelona
Research Site, Cambridge
Research Site, Coventry
Research Site, Glasgow
Research Site, London
Research Site, Nottingham
Research Site, Salford
Research Site, Sheffield
Lead Sponsor
Amgen
INDUSTRY